文献速递肝病

脂肪肝的肝芯片模型

Liver-on-a-Chip Models of Fatty Liver Disease.
PubMed 文献 · Hepatology · 2020-01-01

本文综述了体外肝脏模型从传统二维静态单层培养到生物打印和肝芯片平台的发展,探讨这些技术在脂肪肝病理生理研究、药物发现及肝病临床医学中的应用前景。

要点

  • 肝芯片等工程化体外模型可更真实模拟肝脏微环境。
  • 这些技术有助于研究脂肪肝病因、进展及药物筛选。
  • 从二维培养到生物打印与芯片平台的演进推动肝病研究转化。

核心结论

  • 肝芯片等工程化体外模型有望变革肝脏基础研究、制药行业和临床医学。

研究设计与样本

  • 综述,讨论体外肝脏模型从传统平面静态单层培养到生物打印和肝芯片平台的进展。

主要发现

  • 过去十年工程化体外肝脏模型用于研究脂肪肝病理生理、进展及药物发现。
  • 脂肪肝可进展为肝硬化和肝癌,需更贴近生理的模型研究其机制。

临床怎么用

  • 肝芯片等模型可用于脂肪肝病理生理研究和药物筛选,辅助临床转化研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As a consequence of the obesity epidemic and increasing incidence of metabolic syndrome fatty liver disease now affects a large portion of the world’s population. Left untreated, fatty liver disease can progress to more severe pathologic conditions such as cirrhosis and liver cancer. In an effort to probe the pathophysiology of fatty liver disease and its progression, research over the last decade has led to the engineering of in vitro models of the liver to aid in drug discovery and study of liver pathophysiology. In this review, we discuss advances in modeling liver tissue and the latest developments in understanding disease etiology and treatment from the perspective of engineered in vitro models spanning from conventional planar, static monolayer cultures to those based on the more recently developed bioprinted and liver-on-a-chip platforms. These technologies promise to transform basic biological research, the pharmaceutical industry, and clinical medicine of the liver.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Hassan S, Sebastian S, Maharjan S, et al. Liver-on-a-Chip Models of Fatty Liver Disease. Hepatology. 2020. PMID: 31909504. doi:10.1002/hep.31106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。